Abstract 1260: First-in-class, orally bioavailable KRASG12V(ON) tri-complex inhibitors, as single agents and in combinations, drive profound anti-tumor activity in preclinical models of KRASG12V mutant cancers

Name: Work Video:
Duration: 3 min 30 s
Elena S. Koltun; Jim Cregg; Meghan A. Rice; Dan Whalen; Rebecca Freilich; Jingjing Jiang; Richard L. Hansen; Alun Bermingham; John E. Knox; Jay Dinglasan; Kyle J. Seamon; Cristina Blaj; Stephanie Chang; Yang Liu; Jun Huang; Kang-Jye Chou; Laura McDowell; Bianca J. Lee; David Wildes; Zhengping Wang; Mallika Singh; Adrian L. Gill; Jacqueline A.M. Smith
{'id': 'https://openalex.org/W3178208745', 'doi': 'https://doi.org/10.1158/1538-7445.am2021-1260', 'title': 'Abstract 1260: First-in-class, orally bioavailable KRASG12V(ON) tri-complex inhibitors, as single agents and in combinations, drive profound anti-tumor activity in preclinical models of KRASG12V mutant cancers', 'display_name': 'Abstract 1260: First-in-class, orally bioavailable KRASG12V(ON) tri-complex inhibitors, as single agents and in combinations, drive profound anti-tumor activity in preclinical models of KRASG12V mutant cancers', 'publication_year': 2021, 'publication_date': '2021-07-01', 'ids': {'openalex': 'https://openalex.org/W3178208745', 'doi': 'https://doi.org/10.1158/1538-7445.am2021-1260', 'mag': '3178208745'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2021-1260', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5040036103', 'display_name': 'Elena S. Koltun', 'orcid': 'https://orcid.org/0009-0005-8720-9097'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Elena Koltun', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA;'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA;', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078573857', 'display_name': 'Jim Cregg', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jim Cregg', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053936114', 'display_name': 'Meghan A. Rice', 'orcid': 'https://orcid.org/0000-0003-4578-0461'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Meghan A. Rice', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112199984', 'display_name': 'Dan Whalen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Dan M. Whalen', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058039666', 'display_name': 'Rebecca Freilich', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Rebecca Freilich', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101768843', 'display_name': 'Jingjing Jiang', 'orcid': 'https://orcid.org/0000-0002-5646-6040'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jingjing Jiang', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5066537541', 'display_name': 'Richard L. Hansen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Richard Hansen', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5071778044', 'display_name': 'Alun Bermingham', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Alun Bermingham', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5041603099', 'display_name': 'John E. Knox', 'orcid': 'https://orcid.org/0009-0006-6246-5198'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'John E. Knox', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5088988930', 'display_name': 'Jay Dinglasan', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jay Dinglasan', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039694843', 'display_name': 'Kyle J. Seamon', 'orcid': 'https://orcid.org/0009-0005-5028-3752'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kyle Seamon', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078182587', 'display_name': 'Cristina Blaj', 'orcid': 'https://orcid.org/0000-0003-0449-2690'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Cristina Blaj', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069084946', 'display_name': 'Stephanie Chang', 'orcid': 'https://orcid.org/0009-0000-2026-5215'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Stephanie S. Chang', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100355773', 'display_name': 'Yang Liu', 'orcid': 'https://orcid.org/0000-0002-0367-8189'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yang Liu', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5020833067', 'display_name': 'Jun Huang', 'orcid': 'https://orcid.org/0000-0002-4071-0926'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jun Huang', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002869939', 'display_name': 'Kang-Jye Chou', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kang-Jye Chou', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5048760615', 'display_name': 'Laura McDowell', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Laura McDowell', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5090760997', 'display_name': 'Bianca J. Lee', 'orcid': 'https://orcid.org/0009-0000-4888-8684'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bianca J. Lee', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038156337', 'display_name': 'David Wildes', 'orcid': 'https://orcid.org/0009-0009-3855-7270'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David Wildes', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102845474', 'display_name': 'Zhengping Wang', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Zhengping Wang', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5057362852', 'display_name': 'Mallika Singh', 'orcid': 'https://orcid.org/0009-0003-0234-1589'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mallika Singh', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022776516', 'display_name': 'Adrian L. Gill', 'orcid': 'https://orcid.org/0009-0003-0914-4860'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Adrian L. Gill', 'raw_affiliation_strings': ['2Revolution Medicines, redwood city, CA.'], 'affiliations': [{'raw_affiliation_string': '2Revolution Medicines, redwood city, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5027330002', 'display_name': 'Jacqueline A.M. Smith', 'orcid': 'https://orcid.org/0000-0001-5028-8725'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jacqueline A. Smith', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA;'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA;', 'institution_ids': ['https://openalex.org/I4210100604']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 2.072, 'has_fulltext': False, 'cited_by_count': 26, 'citation_normalized_percentile': {'value': 0.999981, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 95, 'max': 96}, 'biblio': {'volume': '81', 'issue': '13_Supplement', 'first_page': '1260', 'last_page': '1260'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12620', 'display_name': 'Signaling Pathways in Disease', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12620', 'display_name': 'Signaling Pathways in Disease', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12505', 'display_name': 'Peptidase Inhibition and Analysis', 'score': 0.995, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12827', 'display_name': 'Biochemical and Molecular Research', 'score': 0.9928, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/cypa', 'display_name': 'Cypa', 'score': 0.6536906}], 'concepts': [{'id': 'https://openalex.org/C2780778672', 'wikidata': 'https://www.wikidata.org/wiki/Q1756880', 'display_name': 'Cypa', 'level': 3, 'score': 0.6536906}, {'id': 'https://openalex.org/C207332259', 'wikidata': 'https://www.wikidata.org/wiki/Q769143', 'display_name': 'GTPase', 'level': 2, 'score': 0.6106541}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.57501435}, {'id': 'https://openalex.org/C207001950', 'wikidata': 'https://www.wikidata.org/wiki/Q141124', 'display_name': 'In vivo', 'level': 2, 'score': 0.53095645}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.50102234}, {'id': 'https://openalex.org/C143065580', 'wikidata': 'https://www.wikidata.org/wiki/Q3285695', 'display_name': 'Mutant', 'level': 3, 'score': 0.4603389}, {'id': 'https://openalex.org/C51785407', 'wikidata': 'https://www.wikidata.org/wiki/Q2627568', 'display_name': 'Effector', 'level': 2, 'score': 0.44458646}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.40176392}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.39010662}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.36232448}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.3032895}, {'id': 'https://openalex.org/C2909439513', 'wikidata': 'https://www.wikidata.org/wiki/Q18030682', 'display_name': 'Cyclophilin A', 'level': 2, 'score': 0.23617336}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.17682287}, {'id': 'https://openalex.org/C153911025', 'wikidata': 'https://www.wikidata.org/wiki/Q7202', 'display_name': 'Molecular biology', 'level': 1, 'score': 0.16194555}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C150903083', 'wikidata': 'https://www.wikidata.org/wiki/Q7108', 'display_name': 'Biotechnology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2021-1260', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.54, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4383058836', 'https://openalex.org/W3025697856', 'https://openalex.org/W2886643431', 'https://openalex.org/W2357606050', 'https://openalex.org/W2346361101', 'https://openalex.org/W2334046684', 'https://openalex.org/W2144290486', 'https://openalex.org/W2066131420', 'https://openalex.org/W2061444329', 'https://openalex.org/W1984806569'], 'abstract_inverted_index': {'Abstract': [0], 'KRASG12V': [1, 20, 85, 169, 248, 286, 306, 472], 'mutant': [2, 249, 287, 305, 473], 'cancers': [3, 35, 389, 474], 'represent': [4], 'a': [5, 125, 147, 308, 391], 'significant': [6], 'unmet': [7, 394], 'medical': [8, 395], 'need': [9], 'with': [10, 74, 269, 327, 390], 'nearly': [11], '44,000': [12], 'new': [13], 'diagnoses': [14], 'annually': [15], 'in': [16, 24, 30, 62, 207, 232, 272, 314, 362, 462, 468], 'the': [17, 28, 63, 98, 139, 150, 152, 158, 230, 301, 385, 479], 'US.': [18], 'The': [19, 79, 297], 'mutation': [21], 'occurs': [22], 'frequently': [23], 'multiple': [25, 132], 'tumor': [26, 203, 216, 233, 244, 267], 'histotypes;': [27], 'incidence': [29], 'NSCLC,': [31, 250], 'CRC': [32, 251], 'and': [33, 39, 51, 157, 192, 199, 252, 262, 265, 283, 337, 461, 491], 'pancreatic': [34, 253], 'is': [36, 86, 223, 260], '6%,': [37], '10%': [38], '26%,': [40], 'respectively.': [41], 'RAS': [42, 58, 184, 204], 'proteins': [43, 59, 281], 'are': [44, 356], 'small': [45, 128], 'GTPases': [46], 'that': [47, 90, 145, 225, 353], 'drive': [48, 464], 'cell': [49, 166], 'proliferation': [50], 'survival': [52], 'when': [53], 'bound': [54], 'to': [55, 68, 120, 181, 220, 236, 240, 299, 358, 378], 'GTP.': [56], 'Mutant': [57], 'exist': [60], 'predominantly': [61], 'GTP-bound': [64, 160, 302], '(RAS(ON))': [65], 'state,': [66], 'leading': [67, 180], 'excessive': [69], 'downstream': [70, 338], 'signaling': [71], 'via': [72], 'interaction': [73], 'effectors': [75], 'such': [76], 'as': [77, 344, 346, 458], 'RAF.': [78], 'intrinsic': [80], 'GTP': [81], 'hydrolysis': [82], 'rate': [83], 'of': [84, 91, 107, 115, 127, 142, 162, 177, 183, 202, 215, 229, 247, 257, 304, 311, 342, 371, 387, 471, 478], 'significantly': [87], 'lower': [88], 'than': [89], 'either': [92], 'KRASG12C': [93], 'or': [94], 'KRASG12D.': [95], 'Therefore,': [96], 'targeting': [97, 131, 329], 'KRASG12V(ON)': [99, 116, 143, 171, 194, 258, 275, 320, 355, 455], 'state': [100, 161], 'will': [101], 'be': [102, 323], 'critical': [103], 'for': [104, 325, 384, 482], 'maximal': [105], 'suppression': [106, 201], 'this': [108], 'oncogenic': [109, 133], 'driver.': [110], 'No': [111], 'targeted,': [112], 'direct': [113], 'inhibitors': [114, 130, 144, 172, 195, 231, 259, 276, 352, 375], 'have': [117, 123], 'been': [118], 'described': [119], 'date.': [121], 'We': [122], 'built': [124], 'pipeline': [126], 'molecule': [129], 'RAS(ON)': [134], 'mutants.': [135], 'Here': [136], 'we': [137], 'describe': [138], 'preclinical': [140, 469], 'profile': [141], 'promote': [146], 'tri-complex': [148, 456], 'between': [149], 'inhibitor,': [151], 'immunophilin': [153], 'cyclophilin': [154], 'A': [155], '(CypA),': [156], 'active': [159], 'KRASG12V.': [163], 'In': [164, 242], 'cancer': [165, 288, 315, 364], 'lines': [167], 'bearing': [168], 'mutations,': [170], 'trigger': [173], 'an': [174, 368, 379], 'immediate': [175], 'disruption': [176], 'RAS-effector': [178], 'interactions,': [179], 'attenuation': [182], 'pathway': [185, 205, 330], 'signaling,': [186], 'potent': [187], '(sub-nM': [188], 'EC50)': [189], 'growth': [190], 'suppression,': [191], 'apoptosis.': [193], 'produce': [196], 'deep,': [197], 'durable,': [198], 'dose-dependent': [200], 'activation': [206], 'vivo': [208], 'following': [209], 'oral': [210, 255], 'administration.': [211], 'An': [212], 'extended': [213], 'duration': [214], 'pharmacodynamic': [217], 'activity,': [218], 'relative': [219], 'plasma': [221], 'exposure,': [222], 'observed': [224], 'likely': [226], 'reflects': [227], 'retention': [228], 'tissue': [234], 'due': [235], 'high': [237, 393], 'affinity': [238], 'binding': [239], 'CypA.': [241], 'human': [243], 'xenograft': [245], 'models': [246, 470], 'cancers,': [254], 'administration': [256], 'well-tolerated': [261], 'drives': [263], 'profound': [264, 465], 'durable': [266], 'regressions,': [268], 'complete': [270], 'responses': [271], 'some': [273], 'animals.': [274], 'also': [277], 'downregulate': [278], 'immune': [279], 'checkpoint': [280], 'PD-L1': [282], 'CD73': [284], 'on': [285], 'cells,': [289], 'changes': [290], 'which': [291], 'can': [292], 'support': [293], 'enhanced': [294], 'anti-tumor': [295, 466], 'immunity.': [296], 'ability': [298], 'target': [300, 354], 'form': [303], 'permits': [307], 'broad': [309], 'array': [310], 'combination': [312], 'opportunities': [313], 'types': [316], 'where': [317], 'single': [318, 459], 'agent': [319], 'inhibition': [321], 'may': [322, 376], 'insufficient,': [324], 'example': [326], 'agents': [328, 460], 'nodes': [331], 'both': [332], 'upstream': [333], '(e.g.': [334, 339, 349], 'SHP2,': [335], 'SOS1)': [336], 'MEK,': [340], 'ERK)': [341], 'RAS,': [343], 'well': [345], 'parallel': [347], 'pathways': [348], 'mTORC1).': [350], 'Tri-complex': [351], 'predicted': [357], 'combat': [359], 'escape': [360], 'mechanisms': [361], 'RAS-addicted': [363, 388], 'cells': [365], 'characterized': [366], 'by': [367], 'increased': [369], 'pool': [370], 'activated': [372], 'KRASG12V(ON).': [373], 'These': [374], 'lead': [377], 'attractive,': [380], 'targeted': [381], 'therapeutic': [382], 'option': [383], 'treatment': [386], 'very': [392], 'need.': [396], 'Citation': [397], 'Format:': [398], 'Elena': [399], 'Koltun,': [400], 'Jim': [401], 'Cregg,': [402], 'Meghan': [403], 'A.': [404, 450], 'Rice,': [405], 'Dan': [406], 'M.': [407], 'Whalen,': [408], 'Rebecca': [409], 'Freilich,': [410], 'Jingjing': [411], 'Jiang,': [412], 'Richard': [413], 'Hansen,': [414], 'Alun': [415], 'Bermingham,': [416], 'John': [417], 'E.': [418], 'Knox,': [419], 'Jay': [420], 'Dinglasan,': [421], 'Kyle': [422], 'Seamon,': [423], 'Cristina': [424], 'Blaj,': [425], 'Stephanie': [426], 'S.': [427], 'Chang,': [428], 'Yang': [429], 'Liu,': [430], 'Jun': [431], 'Huang,': [432], 'Kang-Jye': [433], 'Chou,': [434], 'Laura': [435], 'McDowell,': [436], 'Bianca': [437], 'J.': [438], 'Lee,': [439], 'David': [440], 'Wildes,': [441], 'Zhengping': [442], 'Wang,': [443], 'Mallika': [444], 'Singh,': [445], 'Adrian': [446], 'L.': [447], 'Gill,': [448], 'Jacqueline': [449], 'Smith.': [451], 'First-in-class,': [452], 'orally': [453], 'bioavailable': [454], 'inhibitors,': [457], 'combinations,': [463], 'activity': [467], '[abstract].': [475], 'In:': [476], 'Proceedings': [477], 'American': [480], 'Association': [481], 'Cancer': [483, 497], 'Research': [484], 'Annual': [485], 'Meeting': [486], '2021;': [487], '2021': [488], 'Apr': [489], '10-15': [490], 'May': [492], '17-21.': [493], 'Philadelphia': [494], '(PA):': [495], 'AACR;': [496], 'Res': [498], '2021;81(13_Suppl):Abstract': [499], 'nr': [500], '1260.': [501]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3178208745', 'counts_by_year': [{'year': 2024, 'cited_by_count': 7}, {'year': 2023, 'cited_by_count': 8}, {'year': 2022, 'cited_by_count': 8}, {'year': 2021, 'cited_by_count': 3}], 'updated_date': '2024-12-16T09:42:50.267703', 'created_date': '2021-07-19'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
